Summary
High dose immunoglobulin infusions showed a marked effect on platelet counts in eight out of nine chronic ITP patients and in one SLE patient. In the comparison of different IgG-preparations, the pepsin treated IgG F (ab′)2 showed no platelet elevation while the sulfonated did. The elevated platelet count could not be maintained after discontinuation of IgG infusions, but in six out of ten patients the platelet level remained above the pretreatment values. This new treatment seems to be safe and effective in adulthood ITP.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Karpatkin S (1980) Autoimmune thrombocytopenic purpura. Blood 56: 329–343
McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304: 1135–1147
Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS, Brunskill DE, Pall LM (1978) The treatment of idiopathic thrombocytopenia with Vinblastin-loaded platelets. N Engl J Med 298: 1101
Branda RF, McCullough JJ, Tate DY, Jacob HS (1978) Plasma exchange in the treatment of fulminant idiopathic (autoimmune) thrombocytopenic purpura. Lancet I: 688–690
Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet I: 1228–1231
Wybran J, Fudenberg HH (1972) Cellular immunity to platelets in idiopathic thrombocytopenic purpura. Blood 40: 856–861
Waldschmidt R, Mueller-Eckhardt C (1979) Stimulation of lymphocytes by platelet-antibody-complexes and their role in the pathogenesis of idiopathic thrombocytopenia. Blut 39: 53–60
Fehr J, Hofmann V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. N Engl J Med 306: 1254–1258
Schmidt R, Budde U, Schafer G, Stroehmann I (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet II: 475–476
Newland AC, Minchinton RM, Treleaven J, Berney S, Waters AH (1983) High-dose intravenous IgG in adult idiopathic thrombocytopenic purpura. Lancet I: 84–87
McMillan R, Longmire RL, Tavassoli M, Armstrong S, Yelenosky R (1974) In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura. N Engl J Med 290: 249–251
Shulman NR, Marder VI, Weinrach RS (1965) Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: Physiologic, serologic and isotopic studies. Ann NY Acid Sci 124: 499–542
Karpatkin S, Siskin GW (1969) In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood 33: 759–812
Dixon RH, Rosse WF (1975) Platelet antibody in immune thrombocytopenia. Br J Haematol 31: 129–134
Dixon R, Rosse WF, Ebbert L (1975) Quantitative determination of antibody in idiopathic thrombocytopenic purpura; correlation of serum and platelet-bound antibody with clinical response. N Engl J Med 292: 230–236
Hegde UV, Gordon-Smith EC, Worlledge S (1977) Platelet antibodies in thrombocytopenic patients. Br J Haematol 35: 113–122
Abe T, Matsuda J (1981) A study of new enzyme immunoassay for quantification of platelet bound IgG and its clinical significance. In: Nydegger UE (ed) Immunohemotherapy. A guide to immunoglobulin prophylaxis and therapy. Academic Press, New York, pp 409–418
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abe, T., Matsuda, J., Kawasugi, K. et al. Clinical effect of intravenous immunoglobulin on chronic idiopathic thrombocytopenic purpura. Blut 47, 69–75 (1983). https://doi.org/10.1007/BF02482640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02482640